Innoviva (INVA) Interest Coverage Ratio (QoQ) (2010 - 2025)
Innoviva (INVA) Interest Coverage Ratio (QoQ) (2010 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Innoviva |
1.65 Bn |
1.05 Bn |
75.83 Mn |
| Date | Value |
|---|
| Sep 30, 2025 |
-17.62% |
| Jun 30, 2025 |
18.89% |
| Sep 30, 2024 |
-21.00% |
| Jun 30, 2024 |
639.19% |
| Sep 30, 2023 |
989.79% |
| Jun 30, 2023 |
14.26% |
| Sep 30, 2022 |
100.04% |
| Jun 30, 2022 |
13.47% |
| Sep 30, 2021 |
-2.98% |
| Jun 30, 2021 |
1,857.17% |
| Mar 31, 2021 |
16.55% |
| Dec 31, 2020 |
-107.56% |
| Sep 30, 2020 |
10.38% |
| Jun 30, 2020 |
-1.41% |
| Mar 31, 2020 |
7.32% |
| Dec 31, 2019 |
21.23% |
| Sep 30, 2019 |
1.03% |
| Jun 30, 2019 |
13.47% |
| Mar 31, 2019 |
-32.97% |
| Dec 31, 2018 |
53.13% |
